← All trials
NCT00340379
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2003
- Primary completion
- Aug 1, 2005
- Completion date
- Aug 1, 2005
- First posted
- —
- Last posted
- —
- Enrollment
- 72
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Duke UniversityLead sponsor
- Duke UniversityOverall official - principal investigator
- University of Southern CaliforniaOverall official - principal investigator
- Alexandria UniversityOverall official - principal investigator
- PfizerCollaborator
- National Institute of Mental Health and Neuro Sciences, IndiaCollaborator
- National Institute of Mental Health and Neuro Sciences, IndiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.